Literature DB >> 35081236

Update of the recommendations of the Sociedade Portuguesa de Cuidados Intensivos and the Infection and Sepsis Group for the approach to COVID-19 in Intensive Care Medicine.

João João Mendes1,2, José Artur Paiva3,4,5, Filipe Gonzalez1,6, Paulo Mergulhão1,4,7, Filipe Froes8, Roberto Roncon5, João Gouveia1,9.   

Abstract

INTRODUCTION: The Sociedade Portuguesa de Cuidados Intensivos and the Infection and Sepsis Group have previously issued health service and management recommendations for critically ill patients with COVID-19. Due to the evolution of knowledge, the panel of experts was again convened to review the current evidence and issue updated recommendations.
METHODS: A national panel of experts who declared that they had no conflicts of interest regarding the development of the recommendations was assembled. Operational questions were developed based on the PICO methodology, and a rapid systematic review was conducted by consulting different bibliographic sources. The panel determined the direction and strength of the recommendations using two Delphi rounds, conducted in accordance with the principles of the GRADE system. A strong recommendation received the wording "is recommended", and a weak recommendation was written as "is suggested."
RESULTS: A total of 48 recommendations and 30 suggestions were issued, covering the following topics: diagnosis of SARS-CoV-2 infection, coinfection and superinfection; criteria for admission, cure and suspension of isolation; organization of services; personal protective equipment; and respiratory support and other specific therapies (antivirals, immunomodulators and anticoagulation).
CONCLUSION: These recommendations, specifically oriented to the Portuguese reality but that may also apply to Portuguese-speaking African countries and East Timor, aim to support health professionals in the management of critically ill patients with COVID-19. They will be continuously reviewed to reflect the progress of our understanding and the treatment of this pathology.

Entities:  

Mesh:

Year:  2022        PMID: 35081236      PMCID: PMC8889599          DOI: 10.5935/0103-507X.0103-507X-rbti-20210080

Source DB:  PubMed          Journal:  Rev Bras Ter Intensiva        ISSN: 0103-507X


  296 in total

1.  The variability of critical care bed numbers in Europe.

Authors:  A Rhodes; P Ferdinande; H Flaatten; B Guidet; P G Metnitz; R P Moreno
Journal:  Intensive Care Med       Date:  2012-07-10       Impact factor: 17.440

2.  [Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia].

Authors: 
Journal:  Zhonghua Jie He He Hu Xi Za Zhi       Date:  2020-03-12

3.  Clinical and immunological features of severe and moderate coronavirus disease 2019.

Authors:  Guang Chen; Di Wu; Wei Guo; Yong Cao; Da Huang; Hongwu Wang; Tao Wang; Xiaoyun Zhang; Huilong Chen; Haijing Yu; Xiaoping Zhang; Minxia Zhang; Shiji Wu; Jianxin Song; Tao Chen; Meifang Han; Shusheng Li; Xiaoping Luo; Jianping Zhao; Qin Ning
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

4.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.

Authors:  Jasper Fuk-Woo Chan; Shuofeng Yuan; Kin-Hang Kok; Kelvin Kai-Wang To; Hin Chu; Jin Yang; Fanfan Xing; Jieling Liu; Cyril Chik-Yan Yip; Rosana Wing-Shan Poon; Hoi-Wah Tsoi; Simon Kam-Fai Lo; Kwok-Hung Chan; Vincent Kwok-Man Poon; Wan-Mui Chan; Jonathan Daniel Ip; Jian-Piao Cai; Vincent Chi-Chung Cheng; Honglin Chen; Christopher Kim-Ming Hui; Kwok-Yung Yuen
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

5.  Evaluation of procalcitonin as a contribution to antimicrobial stewardship in SARS-CoV-2 infection: a retrospective cohort study.

Authors:  E J Williams; L Mair; T I de Silva; D J Green; P House; K Cawthron; C Gillies; J Wigfull; H Parsons; D G Partridge
Journal:  J Hosp Infect       Date:  2021-01-20       Impact factor: 3.926

6.  Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.

Authors:  Anthony C Gordon; Paul R Mouncey; Farah Al-Beidh; Kathryn M Rowan; Alistair D Nichol; Yaseen M Arabi; Djillali Annane; Abi Beane; Wilma van Bentum-Puijk; Lindsay R Berry; Zahra Bhimani; Marc J M Bonten; Charlotte A Bradbury; Frank M Brunkhorst; Adrian Buzgau; Allen C Cheng; Michelle A Detry; Eamon J Duffy; Lise J Estcourt; Mark Fitzgerald; Herman Goossens; Rashan Haniffa; Alisa M Higgins; Thomas E Hills; Christopher M Horvat; Francois Lamontagne; Patrick R Lawler; Helen L Leavis; Kelsey M Linstrum; Edward Litton; Elizabeth Lorenzi; John C Marshall; Florian B Mayr; Daniel F McAuley; Anna McGlothlin; Shay P McGuinness; Bryan J McVerry; Stephanie K Montgomery; Susan C Morpeth; Srinivas Murthy; Katrina Orr; Rachael L Parke; Jane C Parker; Asad E Patanwala; Ville Pettilä; Emma Rademaker; Marlene S Santos; Christina T Saunders; Christopher W Seymour; Manu Shankar-Hari; Wendy I Sligl; Alexis F Turgeon; Anne M Turner; Frank L van de Veerdonk; Ryan Zarychanski; Cameron Green; Roger J Lewis; Derek C Angus; Colin J McArthur; Scott Berry; Steve A Webb; Lennie P G Derde
Journal:  N Engl J Med       Date:  2021-02-25       Impact factor: 91.245

7.  Balanced Crystalloids versus Saline in Sepsis. A Secondary Analysis of the SMART Clinical Trial.

Authors:  Ryan M Brown; Li Wang; Taylor D Coston; Nathan I Krishnan; Jonathan D Casey; Jonathan P Wanderer; Jesse M Ehrenfeld; Daniel W Byrne; Joanna L Stollings; Edward D Siew; Gordon R Bernard; Wesley H Self; Todd W Rice; Matthew W Semler
Journal:  Am J Respir Crit Care Med       Date:  2019-12-15       Impact factor: 21.405

8.  COVID-19 Does Not Lead to a "Typical" Acute Respiratory Distress Syndrome.

Authors:  Luciano Gattinoni; Silvia Coppola; Massimo Cressoni; Mattia Busana; Sandra Rossi; Davide Chiumello
Journal:  Am J Respir Crit Care Med       Date:  2020-05-15       Impact factor: 21.405

9.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

10.  Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19.

Authors:  Marisa Dolhnikoff; Amaro Nunes Duarte-Neto; Renata Aparecida de Almeida Monteiro; Luiz Fernando Ferraz da Silva; Ellen Pierre de Oliveira; Paulo Hilário Nascimento Saldiva; Thais Mauad; Elnara Marcia Negri
Journal:  J Thromb Haemost       Date:  2020-06       Impact factor: 16.036

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.